Whether we suffer from high blood pressure or mental health issues, or know someone who has faced a cancer diagnosis or undergoing treatment for diabetes - NCDs (Non-communicable diseases) impact all of us…
Yet global commitment and action to address the burden of NCDs is not on par with their impact on our everyday lives.
reach52 is proud to contribute and be featured as a case study in this report that outlines four interconnected fronts that guide the innovative pharmaceutical industry’s action on NCDs:
💉 Innovation: Investing in the discovery of new medicines and vaccines to prevent and fight disease
🗣 Availability: Promoting policies that drive expanded access to care
🙋🏽♀️: Empowerment of people living with NCDs: Ensuring the design and implementation of policy solutions are co-created with people living with NCDs
🏥: Capacity building: Working with health systems and their funders to build capacity that can effectively prevent, diagnose, treat and manage life-long conditions.
Read this important report and check out case studies of other organisations working tirelessly to build capacity, ensure access to care, and empower those living with NCDs.